Benson Tsang

Mr. Tsang was the Chief Financial Officer of WuXi Pharmatech Inc. and had led its IPO exercise in 2007, and was an Independent Director of ShangPharma Corp. Mr. Tsang also previously held senior positions at ATA (NASDAQ: ATAI), PCCW (0008:HK), Imation Corp., Coopers & Lybrand (HK) and Deloitte (Canada).

Mr. Tsang has over 30 years of experience in accounting, finance, merger & acquisition, business operations, company restructure, leading IPO and investor relations. He is currently an Independent Director of Athenex Inc. (NASDAQ: ATNX) and Pharmaron Beijing Co. Ltd. (3759.HK). Mr. Tsang is a member of HKCPA and CPA (Canada). He holds a Bachelor’s and an MBA from McMaster University.